Compounds > cytarabine

cytarabine and Hematologic Neoplasms

cytarabine has been researched along with Hematologic Neoplasms in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (11.11)18.2507
2000's22 (34.92)29.6817
2010's26 (41.27)24.3611
2020's8 (12.70)2.80

Authors

AuthorsStudies
Fang, S; Gao, A; Hu, X; Hu, Y; Jiang, K; Jin, T; Li, J; Liu, T; Song, P; Tong, L; Wang, P; Xu, L; Zhou, Y1
Adachi, H; Atsuta, Y; Doki, N; Hashimoto, S; Igarashi, A; Kaito, S; Kishida, Y; Kito, S; Kobayashi, T; Konishi, T; Konuma, R; Marumo, A; Mukae, J; Murofushi, KN; Nagata, A; Najima, Y; Noguchi, Y; Ogawa, H; Ohashi, K; Shimizu, H; Shingai, N; Toya, T; Wada, A; Yamada, Y1
Cao, J; Chen, D; Li, S; Liu, X; Lu, Y; Pei, R; Wang, T; Xu, X; Ye, P; Zheng, ZZ1
Biemond, BJ; de Jong, G; Hazenberg, MD; Janssen, JJWM; Meijer, E; Nur, E; Ossenkoppele, GJ; Visser, O; Zeerleder, SS1
Barbon Gauro, J; Heng, MS; Thomas, J; Yaxley, A1
Abu-Sbeih, H; Ali, FS; Curry, JL; Foo, WC; Ge, PS; Luo, W; Neelapu, SS; Okhuysen, PC; Richards, DM; Tang, T; Wang, Y; Westin, JR1
Kong, P; Yao, H1
Brown, P; Cooper, S; Felling, RJ; Gottesman, RF; Sun, LR; Torriente, AG; Ziai, W1
Chan, O; Idrees, A; Kerr, D; Kharfan-Dabaja, MA; Lancet, JE; Mo, Q; Sokol, L; Sweet, K; Vincelette, ND; Yun, S; Zhang, L1
Lertvivatpong, N; Monsereenusorn, C; Photia, A; Rujkijyanont, P; Ruktrirong, J; Traivaree, C1
Baker, SD; Bishop, MW; Cheng, C; Jeha, S; Karol, SE; Pappo, AS; Pui, CH; Relling, MV; Rubnitz, JE; Sandlund, JT; Smith, C; Stewart, CF; Yang, W1
Cabañas-Perianes, V; Díaz-Carrasco, MS; Espuny-Miró, A; Olmos-Jiménez, R; Valderrey-Pulido, M1
Bertrand, A; Cervos, M; Devaux, Y; Favier, B; Goy, F; Marcault-Derouard, A; Schell, M; Veyet, V1
Andrick, B; Clemmons, AB; DeRemer, D; Gandhi, A; Orr, J; Sportes, C1
Boer, J; Bowman, K; Burke, K; Covington, M; Diamond, S; Dostalik Roman, V; Feng, H; Hall, L; Hollis, G; Huber, R; Koblish, H; Lambert, QT; Li, YL; Marando, C; Margulis, A; Reuther, GW; Scherle, P; Shin, N; Vaddi, K; Wang, K; Wang, Q; Wynn, R; Xue, CB; Yao, W; Yeleswaram, S; Zhang, K1
Banerjee, K; Gibbons, JA; Marier, JF; Vasilinin, G; Wang, Q1
Choudhary, D; Doval, D; Khandelwal, V; Kumar Sharma, S; Kumar, M1
Akahane, D; Asano, M; Gotoh, M; Ito, Y; Katagiri, S; Kitahara, T; Ohyashiki, K; Okabe, S; Suguro, T; Tauchi, T; Yoshizawa, S1
Cui, J; Guo, R; Hoffman, AR; Hu, JF; Li, W; Sun, J; Wang, G; Wang, H1
Berritta, D; Cupri, A; Fauci, AL; Leotta, S; Milone, G; Parisi, M; Spina, P; Tripepi, G1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A1
Badar, T; Borthakur, G; Cortes, J; Ferrajoli, A; Garcia-Manero, G; Kadia, T; Kantarjian, H; Mattiuzzi, G; O'Brien, S; Poku, R; Wierda, W1
Mizuki, M; Morio, K; Sozu, T; Uejima, E1
Onozawa, M; Teshima, T1
Brozova, J; Dobrovolny, J; Kozak, T; Novak, J; Novakova, L1
Romero, D1
Ding, KY; Geng, LQ; Han, YS; Liu, HL; Liu, X; Sun, ZM; Tang, BL; Tong, J; Wan, X; Wang, XB; Wang, ZY; Wu, JS; Wu, Y; Yang, HZ; Yao, W; Zhang, L; Zhang, XH; Zheng, CC; Zhu, WW; Zhu, XY1
Chen, P; Chen, X; Chen, Z; Hu, J; Hua, X; Le, S; Li, J; Lin, Q; Liu, T; Luo, X; Ren, J; Yang, T; Yuan, X; Zhang, L; Zheng, H; Zheng, J; Zheng, X; Zheng, Z1
Díaz-Carrasco, MS; Espuny-Miró, A; Galera-Miñarro, A; Olmos-Jiménez, R; Pascual-Gazquez, JF1
Gill, S1
Chondropoulos, S; Dervenoulas, J; Economopoulos, T; Giannopoulou, V; Girkas, K; Ioannidou, E; Kalli, T; Ladas, SD; Papageorgiou, E; Papaxoinis, G; Pappa, V; Triantafyllou, K; Tsirigotis, P1
Fujimori, Y; Hara, H; Ikegame, K; Itoi, H; Itsukuma, T; Kai, S; Misawa, M; Nakajima, T; Nishioka, K; Ogawa, H; Okada, M; Okikawa, Y; Satake, A; Takatsuka, H; Tamaki, H1
Aisa, Y; Hasegawa, K; Ikeda, Y; Kato, J; Kawata, Y; Kobayashi, N; Kondo, S; Kubo, A; Mori, T; Nagai, T; Nakagawa, T; Okabe, A; Okamoto, S; Shigematsu, N; Tsujimura, N; Tsunoda, K; Yashima, T1
Chan, JC; Kwong, YL; Yeung, DY1
Tallman, MS1
Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P1
Borthakur, G; Giles, FJ; Hagen, S; Jacobsen, TF; Nilsson, B; O'Brien, S; Prebet, T; Ravandi, F; Rizzieri, D; Vey, N1
Tormo Díaz, M1
Aoi, J; Fukushima, S; Ihn, H; Inoue, Y; Jinnin, M; Makino, T; Masuguchi, S; Ogata, A; Sakai, K1
Fujisawa, S; Fujita, H; Kanamori, H; Kanda, Y; Kobayashi, T; Mori, T; Nakaseko, C; Nannya, Y; Ohashi, K; Okamoto, S; Sakamaki, H; Sakura, T; Takahashi, S; Tanaka, M; Yokota, A1
Cavenagh, J; Chopra, R; Clark, FJ; Culligan, D; Davies, A; Fuller, S; Hunt, L; Hunter, A; Littlewood, T; Lush, R; Marks, DI; Marsh, J; Milligan, DW; Parker, A; Schey, S; Smith, GM; Towlson, K; Vandenberghe, E; Williams, CD; Yin, J1
Ogawa, M1
Kim, DH; Kim, JG; Lee, KB; Lee, KS; Lee, NY; Sohn, SK; Suh, JS1
Azuma, A; Chubb, S; Guo, Y; Hittelman, W; Huang, P; Jiang, Y; Li, Y; Liu, X; Matsuda, A; Plunkett, W1
Hamaguchi, M; Hirabayashi, N; Iida, H; Inamoto, Y; Iseki, T; Kami, M; Kodera, Y; Maruyama, F; Miyamura, K; Morishima, Y; Morishita, Y; Naoe, T; Nishida, T; Sao, H; Suzuki, R; Takeyama, H; Yano, K1
Cağirgan, S; Ergene, U; Pehlivan, M; Tombuloğlu, M; Yilmaz, M1
Galmarini, CM1
Abe, Y; Imataki, O; Kawakami, K; Kusafuka, K; Tamai, Y1
Celie, JW; Drager, AM; Heimerikx, M; Huijgens, PC; Janssen, JJ; Kerkhoven, RM; Kessler, FL; van den Born, J; Zweegman, S1
Ager, S; Baglin, TP; Barker, P; Bass, G; Bloxham, DM; Boraks, PA; Hood, IM; Jestice, HK; Johnson, D; Mahendra, P; Marcus, RE; Scott, MA1
Gaarsdal, E; Jensen, L; Johnsen, HE; Knudsen, LM; Nielsen, KJ; Nikolaisen, K1
Barbui, T; Bassan, R; Chiodini, B; Cornelli, PE; Cortelazzo, S; Lerede, T; Zucchetti, M1
Fukushima, T; Gotoh, N; Kishi, S; Masada, M; Matsuyama, S; Nakamura, T; Tsutani, H; Ueda, T; Yamauchi, T1
Miyata, Y; Saito, M; Takeyama, H; Yamada, H; Yamamoto, Y1
Ohnishi, K1
Aysev, D; Ertem, M; Gözdasoğlu, S; Taçyildiz, N; Unal, E; Yavuz, G1
Balashova, VA; Bessmel'tsev, SS1
Björkholm, M; Gruber, A; Hansson, M; Steingrimsdottir, H; Svensson, A1
Aranha, FJ; De Souza, CA; Lima Filho, EC; Lorand-Metze, I; Marques, JF; Miranda, EC; Santini, G; Valbonesi, M; Vigorito, AC1
Beran, M; Kantarjian, HM1
Johnson, SA1
Motta, M; Pelizzari, A; Puoti, M; Rossi, G1
Herrera, P; Jodra, MH; Laraña, JG; López, J; Navarro, JL; Odriozola, J; Pérez de Oteyza, J; Ramos, ML; Ramos, P; Roldán, E; Villalón, L; Zamora, C1

Reviews

7 review(s) available for cytarabine and Hematologic Neoplasms

ArticleYear
Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
    Annals of hematology, 2009, Volume: 88, Issue:3

    Topics: Animals; Antineoplastic Agents; Cytarabine; Hematologic Neoplasms; Humans; Injections, Spinal; Methotrexate; Nervous System Diseases

2009
[Hematologic tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

2003
What does over-expression of cN-II enzyme signify in haematological malignancies?
    Leukemia research, 2007, Volume: 31, Issue:10

    Topics: 5'-Nucleotidase; Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Resistance, Neoplasm; Gene Expression; Hematologic Neoplasms; Humans

2007
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Bone marrow transplantation, 1996, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning

1996
[Oral antitumor drugs for hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

    Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Prodrugs; Tretinoin

1999
Topotecan (hycamptin) and topotecan-containing regimens in the treatment of hematologic malignancies.
    Annals of the New York Academy of Sciences, 2000, Volume: 922

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Enzyme Inhibitors; Hematologic Neoplasms; Humans; Topotecan

2000
Nucleoside analogues in the treatment of haematological malignancies.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:6

    Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Cladribine; Clinical Trials as Topic; Cytarabine; Cytosine; Deoxycytidine; Dioxolanes; Economics, Pharmaceutical; Gemcitabine; Guidelines as Topic; Hematologic Neoplasms; Humans; Molecular Structure; Nucleosides; Pentostatin; Vidarabine

2001

Trials

10 trial(s) available for cytarabine and Hematologic Neoplasms

ArticleYear
Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:6

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Hydrocortisone; Infant; Infant, Newborn; Male; Methotrexate; Nausea; Ondansetron; Prospective Studies; Vomiting

2021
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Hig
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:10

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Melphalan; Middle Aged; Morpholines; Nausea; Olanzapine; Ondansetron; Podophyllotoxin; Vomiting

2018
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.
    Bone marrow transplantation, 2014, Volume: 49, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cord Blood Stem Cell Transplantation; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Young Adult

2014
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytara
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cytarabine; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting

2015
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:3

    Topics: Adult; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Prospective Studies; Risk; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation

2013
A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplan
    Bone marrow transplantation, 2004, Volume: 33, Issue:2

    Topics: Adoptive Transfer; Adult; Combined Modality Therapy; Cytarabine; Female; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocytes; Male; Middle Aged; Pilot Projects; Recurrence; Siblings; Survival Analysis; Tissue Donors; Transplantation Chimera; Transplantation, Homologous

2004
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Bone marrow transplantation, 1996, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning

1996
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
    Haematologica, 1998, Volume: 83, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematologic Neoplasms; Humans; Idarubicin; Lymphoproliferative Disorders; Male; Middle Aged

1998
Clinical pharmacology of intermediate and low-dose cytosine arabinoside (ara-C) therapy in patients with hematologic malignancies.
    Advances in experimental medicine and biology, 1998, Volume: 431

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Cytarabine; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged

1998
[Efficacy of granisetron in the prevention of emesis induced by conditioning chemotherapy for allogeneic bone marrow transplantation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13

    Topics: Adolescent; Adult; Antiemetics; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Granisetron; Hematologic Neoplasms; Humans; Male; Middle Aged; Transplantation Conditioning; Vomiting; Whole-Body Irradiation

1998

Other Studies

47 other study(ies) available for cytarabine and Hematologic Neoplasms

ArticleYear
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies.
    European journal of medicinal chemistry, 2019, Jul-01, Volume: 173

    Topics: Checkpoint Kinase 1; Dose-Response Relationship, Drug; Drug Discovery; Hematologic Neoplasms; Humans; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship

2019
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
    Annals of medicine, 2022, Volume: 54, Issue:1

    Topics: Cyclophosphamide; Cytarabine; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Intensity-Modulated; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation

2022
Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia.
    Hematology (Amsterdam, Netherlands), 2023, Volume: 28, Issue:1

    Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Child; Cyclophosphamide; Cytarabine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Recurrence; Retrospective Studies; Transplantation Conditioning

2023
Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies.
    European journal of haematology, 2019, Volume: 103, Issue:5

    Topics: Adolescent; Adult; Aged; Allografts; Cytarabine; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Male; Middle Aged; Myeloproliferative Disorders; Recurrence; Retrospective Studies; Survival Rate

2019
Does a neutropenic diet reduce adverse outcomes in patients undergoing chemotherapy?
    European journal of cancer care, 2020, Volume: 29, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Carmustine; Chemotherapy-Induced Febrile Neutropenia; Cytarabine; Diet Therapy; Enterocolitis, Neutropenic; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies; South Australia

2020
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.
    American journal of clinical oncology, 2019, Volume: 42, Issue:10

    Topics: Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Cohort Studies; Cytarabine; Daunorubicin; Female; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Immunohistochemistry; Immunotherapy, Adoptive; Incidence; Male; Middle Aged; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Thioguanine

2019
    Hematological oncology, 2020, Volume: 38, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cladribine; Cytarabine; Dendritic Cells; Doxorubicin; Hematologic Neoplasms; Humans; Male; Prognosis; Remission Induction; Salvage Therapy

2020
Intrathecal chemotherapy-associated cerebral vasospasm in children with hematologic malignancies.
    Pediatric research, 2021, Volume: 89, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Female; Hematologic Neoplasms; Humans; Injections, Spinal; Male; Prospective Studies; Ultrasonography, Doppler, Transcranial; Vasospasm, Intracranial; Young Adult

2021
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant.
    Blood advances, 2020, 07-28, Volume: 4, Issue:14

    Topics: Cytarabine; Dendritic Cells; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Retrospective Studies

2020
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.
    Cancer, 2017, Sep-15, Volume: 123, Issue:18

    Topics: Adolescent; Age Distribution; Analysis of Variance; Child; Child, Preschool; Cytarabine; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hand-Foot Syndrome; Hematologic Neoplasms; Humans; Incidence; Infusions, Intravenous; Male; Methotrexate; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution

2017
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological adult patients.
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2017, Sep-01, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Hematologic Neoplasms; Humans; Hydrocortisone; Injections, Spinal; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult

2017
[Intravenous chemotherapy at home: A pediatric monocentric experience].
    Bulletin du cancer, 2018, Volume: 105, Issue:2

    Topics: Antineoplastic Agents; Child; Cytarabine; Eye Neoplasms; Female; Glioma; Health Services Accessibility; Hematologic Neoplasms; Home Care Services, Hospital-Based; Humans; Injections, Intravenous; Male; Neoplasms; Oncology Nursing; Pediatric Nursing; Pediatricians; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Time Factors; Vinblastine

2018
Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dose-Response Relationship, Drug; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Mice; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-pim-1; Signal Transduction

2018
Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic Malignancies.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Renal Insufficiency; Treatment Outcome

2019
Cytarabine ears - A side effect of cytarabine therapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:2

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Ear; Female; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Middle Aged

2020
An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
    International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chromatin; Chromosome Aberrations; Chromosomes; Core Binding Factor Alpha 2 Subunit; Cytarabine; DNA; Enhancer Elements, Genetic; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Exome; Gene Expression Regulation, Leukemic; HeLa Cells; Hematologic Neoplasms; Humans; K562 Cells; Leukemia, Myeloid, Acute; Mutation; Polycomb Repressive Complex 2; Promoter Regions, Genetic; RNA, Long Noncoding; Translocation, Genetic

2014
Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.
    Bone marrow transplantation, 2014, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cytarabine; Female; Fibrinogen; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Male; Melphalan; Middle Aged; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning; Young Adult

2014
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:8

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine

2014
Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies.
    Chemotherapy, 2014, Volume: 60, Issue:3

    Topics: Cytarabine; Female; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Diseases

2014
[Ara-C].
    Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73 Suppl 2

    Topics: Antimetabolites, Antineoplastic; Biological Transport; Cytarabine; Drug Administration Schedule; Hematologic Neoplasms; Humans

2015
Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation.
    Clinical and experimental medicine, 2016, Volume: 16, Issue:4

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Carmustine; Cytarabine; Female; Hematologic Neoplasms; Humans; Male; Melphalan; Middle Aged; Mucosal-Associated Invariant T Cells; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous

2016
Haematological cancer: Cytarabine - new standard of care for MCL.
    Nature reviews. Clinical oncology, 2016, Volume: 13, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hematologic Neoplasms; Humans; Lymphoma, Mantle-Cell; Rituximab; Standard of Care

2016
[Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
    Zhonghua yi xue za zhi, 2016, Jul-26, Volume: 96, Issue:28

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; China; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Male; Retrospective Studies; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2016
A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.
    Oncotarget, 2016, Nov-29, Volume: 7, Issue:48

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Recurrence; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome; Vidarabine; Young Adult

2016
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.
    International journal of clinical pharmacy, 2017, Volume: 39, Issue:1

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Female; Headache; Hematologic Neoplasms; Humans; Injections, Spinal; Male; Methotrexate; Prospective Studies; Vomiting

2017
Monkey business: Repurposing a protein from the simian immunodeficiency virus to enhance cytotoxic chemotherapy.
    Science translational medicine, 2017, 02-01, Volume: 9, Issue:375

    Topics: Animals; Cytarabine; Hematologic Neoplasms; Leukemia, Myeloid, Acute; SAM Domain and HD Domain-Containing Protein 1; Simian Immunodeficiency Virus

2017
Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.
    Bone marrow transplantation, 2008, Volume: 42, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capsule Endoscopy; Carmustine; Cytarabine; Female; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Diseases; Male; Melphalan; Middle Aged; Mucositis; Podophyllotoxin; Transplantation, Autologous

2008
Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cord Blood Stem Cell Transplantation; Cytarabine; Feasibility Studies; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Kinetics; Male; Middle Aged; Risk Assessment; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2008
Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.
    International journal of hematology, 2008, Volume: 88, Issue:5

    Topics: Adult; Cytarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Oral Hygiene; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation

2008
Myeloid disease.
    Current opinion in hematology, 2009, Volume: 16, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myeloproliferative Disorders

2009
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:10

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation

2009
Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.
    Leukemia, 2012, Volume: 26, Issue:7

    Topics: Adult; Cytarabine; Hematologic Neoplasms; Humans; Middle Aged; Prognosis; Tissue Distribution

2012
Liposomal cytarabine in central nervous system disease of haematological malignancies: more effective but more toxic?
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2012, Volume: 14, Issue:4

    Topics: Antimetabolites, Antineoplastic; Central Nervous System; Central Nervous System Diseases; Child; Cytarabine; Hematologic Neoplasms; Humans; Liposomes; Medical Oncology; Prognosis; Randomized Controlled Trials as Topic; Spain; Treatment Outcome

2012
Case of blastic plasmacytoid dendritic cell neoplasm.
    The Journal of dermatology, 2012, Volume: 39, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dendritic Cells; Dexamethasone; Doxorubicin; Hematologic Neoplasms; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Skin Neoplasms; Stem Cell Transplantation; Vincristine

2012
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
    Blood, 2002, Nov-01, Volume: 100, Issue:9

    Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cyclosporine; Cytarabine; Data Collection; Etoposide; Female; Follow-Up Studies; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2002
Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
    Cancer research, 2005, Aug-01, Volume: 65, Issue:15

    Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Interactions; G2 Phase; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Mitosis; Protein Kinases; Signal Transduction; Staurosporine

2005
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Chronic Disease; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation

2007
Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2007, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Component Removal; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Kinetics; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Autologous

2007
[Three cases of necrotizing pneumonia by pseudomonas aeruginosa infection in hematological malignancy, including dead and alive cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fatal Outcome; Hematologic Neoplasms; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Neutropenia; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Severity of Illness Index

2007
Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile.
    Matrix biology : journal of the International Society for Matrix Biology, 2007, Volume: 26, Issue:7

    Topics: Animals; Bone Marrow; Cell Line; Cytarabine; Gene Expression Regulation; Glycosaminoglycans; Hematologic Neoplasms; Humans; Mice; Oligonucleotide Array Sequence Analysis; Prostaglandins; Stromal Cells

2007
Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
    Journal of hematotherapy, 1996, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Transfusion, Autologous; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Injections, Subcutaneous; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Recombinant Proteins

1996
Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
    Medical and pediatric oncology, 1999, Volume: 33, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Child; Cytarabine; Female; Fusarium; Hematologic Neoplasms; Humans; Mycoses; Neutropenia; Opportunistic Infections

1999
[The action in vitro of a permanent and an alternating magnetic field and of cytosar on the colony- and cluster-forming properties of bone marrow cells from hematologic patients].
    Likars'ka sprava, 2000, Issue:2

    Topics: Antimetabolites, Antineoplastic; Bone Marrow Cells; Colony-Forming Units Assay; Cytarabine; Hematologic Neoplasms; Humans; Magnetics; Time Factors; Tumor Cells, Cultured

2000
Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Carmustine; Cell Lineage; Combined Modality Therapy; Cytarabine; Disease Susceptibility; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Melphalan; Middle Aged; Podophyllotoxin; Sweden; Transplantation Conditioning; Transplantation, Autologous

2000
Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield.
    Transfusion science, 2000, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Infection Control; Leukapheresis; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Recombinant Proteins; Time Factors

2000
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation

2001
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:6

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Cerebral Hemorrhage; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Erythropoietin; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infections; Leukapheresis; Life Tables; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Transplantation Conditioning; Transplantation, Autologous

2000